If you're interested in exploring whether microdosing may be right for you, you can: Our providers currently serve patients in North Carolina, South Carolina, Texas, New York, Arizona, Florida, Maryland, and additional states
Company: Tailstorm Health Inc., doing business as Medivant Health Type: Compounding pharmacy and FDA-registered outsourcing facilityWarning Letter Date: April 8, 2025FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Facility Location: Phoenix, ArizonaInspection Dates: September 24, 2024, to October 10, 2024
Health Canada typically reviews obesity medications on timelines of 1-2 years following FDA approval in the United States
You will also find out about the possible side effects